Загрузка...
How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet
Resistance to therapeutic agents is a major factor in the failure of cancer treatments. In leukemia, the resistant cells remaining in the bone marrow and/or peripheral blood constitute minimal residual disease and are detectable by highly sensitive assays when the patient appears to be in complete r...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Ferrata Storti Foundation
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2719036/ https://ncbi.nlm.nih.gov/pubmed/19586938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2008.004267 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|